Evidence-Based Guideline for the management of osteoporosis in men

Nicholas R Fuggle¹, Charlotte Beaudart^{2

3}, Olivier Bruyère³, Bo Abrahamsen⁴, Nasser Al-Daghri⁵, Nansa Burlet^{3

6}, Manju Chandran⁷, Mario M Rosa⁸, Bernard Cortet⁹, Céline Demonceau³, Willard Dere¹⁰, Philippe Halbout¹¹, Mickaël Hiligsmann¹², John A Kanis^{13

14}, Jean-Marc Kaufman¹⁵, Andreas Kurth¹⁶, Olivier Lamy¹⁷, Andrea Laslop¹⁸, Stefania Maggi¹⁹, Radmila Matijevic²⁰, Eugene McCloskey¹³, Ali Mobasheri²¹, Maria C Prieto Yerro²², Régis P Radermecker²³, Shaun Sabico⁵, Yousef Al-Saleh^{4

24}, Stuart Silverman²⁵, Nicola Veronese²⁶, René Rizzoli²⁷, Cyrus Cooper^{1

28

29}, Jean-Yves Reginster^{3

30}, Nicholas C Harvey^{31

32}

Affiliations

¹ MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
² Clinical Pharmacology and Toxicology Research Unit, Faculty of Medicine, NARILIS, University of Namur, Namur, Belgium.
³ WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Ageing, Liège, Belgium.
⁴ Odense Patient Data Explorative Network, Institute of Clinical Research University of Southern Denmark, Odense, Denmark.
⁵ Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
⁶ The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), Liege, Belgium.
⁷ Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, DUKE NUS Medical School, Singapore, Singapore.
⁸ Laboratory of Clinical and Therapeutical Pharmacology, University of Lisbon, Lisbon, Portugal.
⁹ Department of Rheumatology, University of Lille, Lille, France.
¹⁰ Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
¹¹ The International Osteoporosis Foundation (IOF), Nyon, Switzerland.
¹² Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
¹³ Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
¹⁴ Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
¹⁵ Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.
¹⁶ Department of Orthopaedic and Trauma Surgery, Community Clinics Middle Rhine, Campus Kemperhof, Koblenz, Germany.
¹⁷ Centre interdisciplinaire des maladies osseuses, Département de l'appareil locomoteur, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.
¹⁸ Scientific Office, Federal Office for Safety in Health Care, Vienna, Austria.
¹⁹ CNR Aging Branch-IN, Padua, Italy.
²⁰ University of Novi Sad, Faculty of Medicine, Clinic for Orthopedic Surgery and Traumatology, Clinical Center of Vojvodina, Novi Sad, Serbia.
²¹ Research Unit of Medical Imaging, Physics, and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.
²² Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
²³ Department of Diabetes, Nutrition and Metabolic disorders, Clinical pharmacology, University of Liège, CHU de Liège, Liège, Belgium.
²⁴ Department of Endocrinology, Dr. Mohammad Alfagih Hospital, Riyadh, Saudi Arabia.
²⁵ Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
²⁶ Department of Internal Medicine, Geriatrics Section, University of Palermo, Palermo, Italy.
²⁷ Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
²⁸ NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
²⁹ NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
³⁰ Protein Research Chair, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
³¹ MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK. nch@mrc.soton.ac.uk.
³² NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK. nch@mrc.soton.ac.uk.

PMID: 38485753
DOI: 10.1038/s41584-024-01094-9

Free article

Review

Evidence-Based Guideline for the management of osteoporosis in men

Nicholas R Fuggle et al. Nat Rev Rheumatol. 2024 Apr.

Free article

. 2024 Apr;20(4):241-251.

doi: 10.1038/s41584-024-01094-9. Epub 2024 Mar 14.

Authors

Affiliations

¹ MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
² Clinical Pharmacology and Toxicology Research Unit, Faculty of Medicine, NARILIS, University of Namur, Namur, Belgium.
³ WHO Collaborating Centre for Epidemiology of Musculoskeletal Health and Ageing, Liège, Belgium.
⁴ Odense Patient Data Explorative Network, Institute of Clinical Research University of Southern Denmark, Odense, Denmark.
⁵ Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
⁶ The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), Liege, Belgium.
⁷ Osteoporosis and Bone Metabolism Unit, Department of Endocrinology, Singapore General Hospital, DUKE NUS Medical School, Singapore, Singapore.
⁸ Laboratory of Clinical and Therapeutical Pharmacology, University of Lisbon, Lisbon, Portugal.
⁹ Department of Rheumatology, University of Lille, Lille, France.
¹⁰ Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
¹¹ The International Osteoporosis Foundation (IOF), Nyon, Switzerland.
¹² Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
¹³ Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
¹⁴ Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
¹⁵ Department of Endocrinology, Ghent University Hospital, Ghent, Belgium.
¹⁶ Department of Orthopaedic and Trauma Surgery, Community Clinics Middle Rhine, Campus Kemperhof, Koblenz, Germany.
¹⁷ Centre interdisciplinaire des maladies osseuses, Département de l'appareil locomoteur, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.
¹⁸ Scientific Office, Federal Office for Safety in Health Care, Vienna, Austria.
¹⁹ CNR Aging Branch-IN, Padua, Italy.
²⁰ University of Novi Sad, Faculty of Medicine, Clinic for Orthopedic Surgery and Traumatology, Clinical Center of Vojvodina, Novi Sad, Serbia.
²¹ Research Unit of Medical Imaging, Physics, and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.
²² Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
²³ Department of Diabetes, Nutrition and Metabolic disorders, Clinical pharmacology, University of Liège, CHU de Liège, Liège, Belgium.
²⁴ Department of Endocrinology, Dr. Mohammad Alfagih Hospital, Riyadh, Saudi Arabia.
²⁵ Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
²⁶ Department of Internal Medicine, Geriatrics Section, University of Palermo, Palermo, Italy.
²⁷ Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
²⁸ NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
²⁹ NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK.
³⁰ Protein Research Chair, Biochemistry Department, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia.
³¹ MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK. nch@mrc.soton.ac.uk.
³² NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK. nch@mrc.soton.ac.uk.

PMID: 38485753
DOI: 10.1038/s41584-024-01094-9

Abstract

Historically, osteoporosis has been viewed as a disease of women, with research, trials of interventions and guidelines predominantly focused as such. It is apparent, however, that this condition causes a substantial health burden in men also, and that its assessment and management must ultimately be addressed across both sexes. In this article, an international multidisciplinary working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases presents GRADE-assessed recommendations for the diagnosis, monitoring and treatment of osteoporosis in men. The recommendations are based on a comprehensive review of the latest research related to diagnostic and screening approaches for osteoporosis and its associated high fracture risk in men, covering disease burden, appropriate interpretation of bone densitometry (including the use of a female reference database for densitometric diagnosis in men) and absolute fracture risk, thresholds for treatment, and interventions that can be used therapeutically and their health economic evaluation. Future work should specifically address the efficacy of anti-osteoporosis medications, including denosumab and bone-forming therapies.

PubMed Disclaimer

References

1. Curtis, E. M. et al. Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status. Bone 87, 19–26 (2016). - PubMed - PMC - DOI
1. Kanis, J. A., Melton, L. J. III, Christiansen, C., Johnston, C. C. & Khaltaev, N. The diagnosis of osteoporosis. J. Bone Min. Res. 9, 1137–1141 (1994). - DOI
1. Orwoll, E. S. & Bliziotes, M. Heterogeneity in osteoporosis. Men versus women. Rheum. Dis. Clin. North. Am. 20, 671–689 (1994). - PubMed - DOI
1. Rinonapoli, G. et al. Osteoporosis in men: a review of an underestimated bone condition. Int. J. Mol. Sci. 22, https://doi.org/10.3390/ijms22042105 (2021).
1. Kanis, J. A. et al. Long-term risk of osteoporotic fracture in Malmö. Osteoporos. Int. 11, 669–674 (2000). - PubMed - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- ORBi (University of Liege)
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Evidence-Based Guideline for the management of osteoporosis in men

Affiliations

Evidence-Based Guideline for the management of osteoporosis in men

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical